Pentwater Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Pentwater Capital Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-998,000	Closed	-$96.8M	–	196
2019 Q3	$96.8M	Buy	998,000 +938,000	+1,563%	+$93.9M	1.51%	14
2019 Q2	$6.14M	Buy	+60,000	New	+$6.47M	0.07%	87

Pentwater Capital Management's ONCE Position: Q4 2019 in Review

Pentwater Capital Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 2,103,545 shares — an estimated $204M sold.

Pentwater Capital Management first reported a position in ONCE in Q2 2019 and held it in 2 quarters. The position peaked at $204M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Pentwater Capital Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Pentwater Capital Management sold 2,103,545 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $204M.
Pentwater Capital Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
Pentwater Capital Management's Spark Therapeutics, Inc. Common Stock position peaked at $204M in Q3 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Pentwater Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.